Evolyutsiya gormonal'noy kontratseptsii (obzor literatury)
- Authors: Pustotina O.A1
-
Affiliations:
- Issue: No 3 (2015)
- Pages: 15-21
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287712
- ID: 287712
Cite item
Abstract
The article presents the literature data on the evolution of hormonal contraception, types and composition of modern hormonal preparations; modes and routes of administration are described; safety data and features of the influence of contraceptives on women's health are discussed.
Keywords
Full Text
References
- Burkman R., Bell C., Serfaty D. The evolution of combined oral contraception: improving the isk to benefit ratio. Contraception. 2011; 84:19-34.
- Pincus G., Chang M.C., Hafez E.S., Zarrow M.X., Merrill A. Effects of certain 19-nor steroids on reproductive processes in animals. Science. 1956;124:890-95.
- Pincus G., Paniagua M., Pendleton A., Laraque F., Nicolas R., Borno R., Pean V. Effectiveness of an oral contraceptive. Science. 1959;130:81.
- Dhont M. History of oral contraception. Eur. J. Contracept Reprod Health Care. 2010;15(S2):12-8.
- Gerstman B.B., Piper J.M., Tomita D.K., Ferguson W.J., Stadel B.V., Lundin F.E. Oral contraceptive estrogen dose and risk of deep venous thromboembolic disease. Am. J. Epidem. 1991;133:32-7.
- Kronenberg H.M., Melmed S., Polonsky K.S., Larsen P.R. Williams Textbook of Endocrinology. 11th edition, Elsevier Ltd., 2008.
- The Oral Contraceptive and Hemostasis Study Group. The effect of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomazed multicenter study. Contraception. 2003;67: 173-85.
- US Selected Practice Recommendations for Contraceptive Use, 2013. http://www.cdc.gov/ mmwr/pdf/rr/rr62e0614.pdf.
- WHO. Medical eligibility criteria for contraceptive use. Fouth edition, 2009. 125 p.
- Speroff L., Fritz M.A. Clinical Gynecologic Endocrinology and Infertility, 7th ed., 2005.
- Clinical Effectiveness Unit. Combined hormonal contraception. London (UK): Faculty of Sexual and Reproductive Healthcare; 2011 http:// guideline.gov/content.aspx?f=rss&id=36071
- Grow D.R. Metabolism of endogenous and exogenous reproductive hormones. Obstet. Gynecol. Clin. North Am. 2002;29:425-36.
- Porter J.B., Hershel J., Walker A.M. Mortality among oral contraceptive users. Obstet. Gynecol. 1987;70:29-32.
- Zeun S., Lu M., Uddin A., Zeiler B., Morrison D., Blode H. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest. Eur. J. Contracept Reprod Health Care. 2009;14:221-32.
- Agren U.M., Anttila M., Maenpaa-Liukko K., Rantala M.L., Rautiainen H., Sommer W.F., Mommers E. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism. Eur. J. Contracept Reprod Health Care. 2011;16:444-57.
- Jensen J.T. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dieogest. Expert Opin. Pharmacother. 2010; 1 1:1147-57.
- Duijkers I.J., Klipping C., Grob P., Korver T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17 beta-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur. J. Contracept Reprod Health Care. 2010;15:314-25.
- Mansour D., Verhoeven C., Sommer W., Weisberg E., Taneepanichskul S., Melis G.B., SundströmPoromaa I., Korver T. Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen. Eur. J. Contracept Reprod Health Care. 2011;16:430-43.
- Westhoff C., Kaunitz A.M., Korver T., Sommer W., Bahamondes L., Darney P., Verhoeven C. Efficacy, safety, and tolerability of a monophasic oral contraceptive containing nomegestrol acetate and 17β-estradiol: a randomized controlled trial. Obstet. Gynecol. 2012;119:989-99.
- Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W., Thijssen J.H. Classification and pharmacology of progestins. Maturitas. 2008;61:171-80.
- Stanczyk F.Z. Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception. Rev. Endocr. Metab. Disord. 2002;3:211-24.
- Lello S. Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy. Drugs. 2010;70:541-59.
- Mueck A.O., Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011;76(6):531-39.
- Christin-Maitre S., Serfaty D., Chabbert-Buffet N., Ochsenbein E., Chassard D., Thomas J.L. Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study. Hum Reprod.2011;26:1338-47.
- Read C.M. New regimens with combined oral contraceptive pills-moving away from traditional 21/7 cycles. Eur. J. Contracept Reprod Health Care. 2010;15(2):32-41.
- Seracchioli R., Mabrouk M., et al. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomised, con trolled trial. Fertil Steril. 2010;93:52-6.
- Klipping C., Duijker I., Fortier M.P., Marr J., Trummer D., Elliesen J. Long-term tolerability of ethinylestradiol 20mg/drospirenone 3 mg in flexible extended regimen: results from a randomized, controlled, multicenter study. J. Fam. Plann Reprod Health Care. 2012;38:84-93.
- Trussel J. Contraceptive Failure in the United States. Contraception. 2011;83:397-404.
- Trussell J., Henry N., Hassan F., Prezioso A., Law A., Filonenko A. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception. 2013;87:154-61.
- Blumenthal P., Gemzell-Danielsson K., Marintcheva-Petrova M. Tolerability And Clinical Safety of IMPLANON®. Eur J Contrac and Reprod Health Care. 2008;13(1):29-36.
- Hatcher R.A., Trussel J., Nelson A.L., et al. Contraceptive Technology. 19th revised ed. New York, NY: Ardent Media, 2007.
- Trussell J., Wynn L.L. Reducing unintended pregnancy in the United States. Contraception. 2008;77:1-9.
- Winner B., Peipert J.F., Zhao Q., Buckel C., Madden T., Allsworth J.E., Secura G.M. Effectiveness of long-acting reversible contraception. N. Engl. J. Med. 2012;366:1998-2008.
- Lidegaard O. Hormonal contraception and venous thromboembolic risk in midlife women. Editorial. Maturitas. 2013;74:1-12.